Related Experiment Video
Updated: Jun 25, 2026
In situ Quantification of Pancreatic Beta-cell Mass in Mice
Published on: June 7, 2010
Pancreatic beta cell mass preserved in heterozygous PDK1 knockout mice
Akihiko Takeda1, Yoshiaki Kido, Naoko Hashimoto
1Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe 17, Japan.
Abstract:
We have demonstrated that 3-phosphoinositide-dependent protein kinase 1 (PDK1) contributes to signaling by insulin or insulin-like growth factor-1 (IGF-1) that is responsible for the regulation of both the number and size of pancreatic beta cells in mice. Complete ablation of PDK1 in pancreatic beta cells leads to progressive hyperglycemia as a result of loss of beta cell mass. In this study, we generated heterozygous pancreatic beta cell-specific PDK1 knockout (betaPDK1+/-) mice and fed them a high-fat diet as a model of human type 2 diabetes. The betaPDK1+/- mice exhibited normal glucose tolerance even on a high-fat diet. Further, islet morphology and beta cell mass were normal in betaPDK1+/- mice, and haploinsufficiency of PDK1 did not impair the compensatory hyperplasia of beta cells on a high-fat diet. The phosphorylation and expression of the molecules that are expressed downstream of PDK1 were similar in the islets of the betaPDK1+/- and control mice. Eventually, we concluded that glucose homeostasis and islet mass were maintained in betaPDK1+/- mice.
Insights
Haploinsufficiency of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in pancreatic beta cells maintains glucose homeostasis and islet mass, even under high-fat diet conditions. This suggests PDK1
Area of Science:
- Endocrinology
- Metabolic diseases
- Cell signaling
Background:
- 3-phosphoinositide-dependent protein kinase 1 (PDK1) is crucial for insulin/IGF-1 signaling pathways.
- PDK1 regulates pancreatic beta cell number and size.
- Complete PDK1 ablation in beta cells causes hyperglycemia and loss of beta cell mass.
Purpose of the Study:
- To investigate the role of PDK1 haploinsufficiency in pancreatic beta cells under high-fat diet conditions.
- To assess glucose tolerance, islet morphology, and beta cell mass in heterozygous PDK1 knockout mice.
- To evaluate the impact of PDK1 haploinsufficiency on compensatory beta cell hyperplasia.
Main Methods:
- Generation of heterozygous pancreatic beta cell-specific PDK1 knockout (betaPDK1+/-) mice.
- High-fat diet feeding to model type 2 diabetes.
- Assessment of glucose tolerance, islet morphology, beta cell mass, and downstream signaling molecule phosphorylation/expression.
Main Results:
- betaPDK1+/- mice maintained normal glucose tolerance on a high-fat diet.
- Islet morphology and beta cell mass remained normal in betaPDK1+/- mice.
- Haploinsufficiency of PDK1 did not impair compensatory beta cell hyperplasia or downstream signaling.
Conclusions:
- Glucose homeostasis and islet mass are maintained in mice with pancreatic beta cell-specific PDK1 haploinsufficiency.
- PDK1 haploinsufficiency does not compromise the adaptive response of beta cells to metabolic stress.
- These findings highlight the resilience of glucose regulation despite reduced PDK1 levels in beta cells.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
10:12Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021